Issue link: https://beckershealthcare.uberflip.com/i/1473998
18 CEO / STRATEGY Fortune 500's top 25 healthcare companies By Molly Gamble T he 68th Fortune 500 was released May 23. e annual list of the largest corporations in the U.S. ranked by revenue for the 2021 fiscal year includes 77 healthcare companies. Key healthcare takeaways from the most recent listing from Fortune: 1. e list includes 11 companies specializing in medical facilities. Of those, Nashville, Tenn.-based HCA Healthcare reigns, holding the 62nd spot overall with $58.75 billion in revenue, up 14 percent year over year. 2. Of the 11 ranked companies specializing in medical facilities, Sur- gery Partners, the Brentwood, Tenn.-based surgical facilities compa- ny, saw the greatest revenue growth at 19.6 percent for $2.22 billion. 3. e list includes six health insurance and managed care companies. UnitedHealth Group comes out on top in this group, landing fih in the Fortune 500 rankings overall with $287.59 billion in revenue, up 11.8 percent year over year. 4. Fieen pharmaceutical and health service companies are ranked, with CVS Health leading this group. It holds the fourth spot in the Fortune 500 rankings overall with $292.11 billion in revenue, up 8.7 percent year over year. 5. Here are the top 25 ranked healthcare companies with their reve- nue and percent change to annual revenue: 4. CVS Health 2021 revenue: $292.11 billion Change to revenue: 8.7 percent 5. UnitedHealthGroup 2021 revenue: $287.59 billion Change to revenue: 11.8 percent 9. McKesson 2021 revenue: $238.22 billion Change to revenue: 3.1 percent 10. AmerisourceBergen 2021 revenue: $213.98 billion Change to revenue: 12.7 percent 12. Cigna 2021 revenue: $174.07 billion Change to revenue: 8.5 percent 15. Cardinal Health 2021 revenue: $162.46 billion Change to revenue: 6.2 percent 20. Anthem 2021 revenue: $138.63 billion Change to revenue: 13.8 percent 26. Centene 2021 revenue: $125.98 billion Change to revenue: 13.4 percent 37. Johnson & Johnson 2021 revenue: $93.77 billion Change to revenue: 13.6 percent 40. Humana 2021 revenue: $83.06 billion Change to revenue: 7.7 percent 43. Pfizer 2021 revenue: $81.28 billion Change to revenue: 94 percent 62. HCA Healthcare 2021 revenue: $58.75 billion Change to revenue: 14 percent 63. AbbVie 2021 revenue: $56.19 billion Change to revenue: 22.7 percent 71. Merck 2021 revenue: $51.21 billion Change to revenue: 6.7 percent 82. Bristol Myers Squibb 2021 revenue: $46.38 billion Change to revenue: 9.1 percent 86. Abbott Laboratories 2021 revenue: $43.07 billion Change to revenue: 24.5 percent 118. Danaher 2021 revenue: $29.45 billion Change to revenue: 32.2 percent 122. Eli Lilly 2021 revenue: $28.31 billion Change to revenue: 15.4 percent 125. Molina Healthcare 2021 revenue: $27.77 billion Change to revenue: 43 percent 129. Gilead Sciences 2021 revenue: $27.3 billion Change to revenue: 10.6 percent 140. Amgen 2021 revenue: $25.97 billion Change to revenue: 2.2 percent 173. Becton Dickinson 2021 revenue: $20.24 billion Change to revenue: 18.3 percent 181. Tenet Healthcare 2021 revenue: $19.48 billion Change to revenue: 10.5 percent 195. Moderna 2021 revenue: $18.47 billion Change to revenue: 2,199 percent 204. Viatris 2021 revenue: $17.88 billion Change to revenue: 49.7 percent n CEO resignations hit record high By Ayla Ellison D ozens of hospital CEOs have resigned this year as a record number of chiefs across all industries have exited their roles, according to a May 18 Challenger, Gray & Christmas report. Nearly 520 CEOs left their posts between Jan. 1 and the end of April, the highest total since the executive outplacement and coaching firm began tracking CEO changes in 2002. The total is up 18 percent from the 440 CEO exits announced in the same period of 2021. Thirty-six hospital CEOs exited their roles in the first four months of this year. That's up from the 20 hospital chiefs who resigned in the same period last year, according to the report. CEOs are leaving their positions and businesses are making changes at the top for several reasons, Chal- lenger, Gray & Christmas Senior Vice President Andrew Challenger said. "Inflation, staffing shortages, and possible recession concerns are giving more cause for companies to re- evaluate leadership," Mr. Challenger said. "This, after years of companies trying to figure out the right formula to attract and retain talent and create a culture of inclu- sion, issues that often start at the top." n